HOME

Scientists have developed a novel nanoparticle vaccine that reportedly prevented or slowed multiple cancer types in mouse models. The innovative approach activates the immune system through multiple pathways to combat tumor growth with remarkable survival rates observed in preclinical testing.

Innovative Cancer Prevention Approach

Researchers at the University of Massachusetts Amherst have developed a groundbreaking nanoparticle-based vaccine that sources indicate can prevent or slow numerous cancer types in mice. According to reports, the vaccine represents a significant advancement in cancer immunotherapy that could eventually benefit high-risk patients.